CG
BMY.RT

Cutler Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Cutler Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-39,848
Closed -$27K – 6658
2020
Q4 		$27K Sell
39,848
-13,531
-25% -$28.8K ﹤0.01% 2469
2020
Q3 		$120K Sell
53,379
-58,785
-52% -$168K 0.01% 1214
2020
Q2 		$401K Sell
112,164
-29,884
-21% -$108K 0.03% 566
2020
Q1 		$539K Sell
142,048
-10,368
-7% -$34.2K 0.03% 530
2019
Q4 		$458K Buy
+152,416
New +$396K 0.03% 479

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Cutler Group's BMY.RT Position: Q1 2021 in Review

Cutler Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 39,848 shares — an estimated $27K sold.

Cutler Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $539K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Cutler Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 39,848 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $27K.
  • Cutler Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Cutler Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $539K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.